KALA BIO, Inc.
KALA BIO, Inc. (KALA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · KALA · as of Jun 8, 2026
Key Statistics
Explore KALA BIO, Inc. Data
kala stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 9 · Buy rate: 55.6%
The KALA analyst consensus is Buy, based on ratings from 9 Wall Street analysts over the past 3 months. The average 12-month price target is $18.25, representing +696.94% upside from the current price of $2.29.
Competitors & Peers
kala competitorsKALA
ABP
AIM
CANF
ENSC
IBOStock Performance
Full HistoryAbout KALA BIO, Inc.
KALA BIO, Inc. functions as a biopharmaceutical company dedicated to the creation and commercialization of new therapeutic solutions. The core of their strategy involves utilizing proprietary nanopart…
what is kala bio, inc. · kala stock overview · kala bio, inc. company profile · who is kala bio, inc. ceo · kala NASDAQ · kala bio, inc. headquarters · kala bio, inc. business segments
About Stock Overview & Key Data
KALA BIO, Inc. (KALA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jul 20, 2017. As of the latest trading session, KALA stock price is $2.29, with a market capitalization of $50.2M. The stock has returned -98.92% over the past 12 months and -92.05% year-to-date.
According to 9 Wall Street analysts, the consensus rating for KALA BIO, Inc. stock is Buy, with an average 12-month price target of $18.25. In fiscal year 2025, KALA BIO, Inc. reported revenue of — and net income of -$27.0M. For detailed data — including KALA BIO, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, KALA BIO, Inc. (KALA) stock price is $2.29. The stock is traded on NASDAQ under the ticker symbol KALA. The 52-week range is $2.10 – $1030.00.